RFWD3 and neoplasm: Despite the evidence that low RFWD3 may convey a favourable cellular phenotype in terms of proliferation, migration, and chemosensitivity, no differences were observed in survival between the RFWD3 low-expressing tumours and RFWD3 mid-expressing tumours during analysis of a HGSOC patient cohort.